A wildfire in a hiking area that had been burning since Saturday in the northwestern New Territories, near the boundary between the Hong Kong Special Administrative Region and Shenzhen, Guangdong province, was largely extinguished by 2:08 pm on Sunday. As of press time, no casualties had been reported.
Morgan Lewis & Bockius’ Shenzhen office, launched less than two years ago, has ceased operations. The firm’s former Shenzhen head and intellectual property partner, Shaobin Zhu, left in November to join DLA Piper in the U.S. Morgan Lewis did not find a successor to lead the Shenzhen outfit, and subsequently closed the office.
From history and culture to sandy beaches, these cities in China are perfect for Hongkongers in need of a quick getaway
The future of developer China Vanke and its $45 billion in debt were in focus on Friday after media reports alleged its CEO had been temporarily detained, deepening concerns about China's embattled property sector.
Investors moved on from the headline number to focus on the durability of the recovery amid a lack of more clarity on stimulus policies.
Chinese cloud-computing and IT infrastructure company Unisplendour Corp. is preparing for a second listing in Hong Kong as soon as this year that could raise about $1 billion, people familiar with the matter said,
Hong Kong deputy financial secretary Michael Wong and Nansha district party chief Liu Wei are among conference’s VIP speakers. Shenzhen residents have been able to apply for multi-entry permits ...
Hong Kong Disneyland said on Thursday that it’s pleased with the theme park’s performance last year in terms of visitor numbers and revenue, and
Luckin Coffee's (LKNCY) expansion into Hong Kong is unlikely to be a game changer due to strong local competition. Read why I'm bearish on the stock.
The first direct high-speed rail service between Xi'an, capital of Shaanxi province, and Hong Kong was launched on Sunday (Jan 5), marking a significant step in connecting China's northwestern inland region with the southern metropolis.
XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the biopharmaceutical industry by leveraging AI and robotics to transform traditional approaches to drug development.